InspireMD (NSPR) Reports Q4 Loss of $0.31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. HNGE
8. INSP
9. MTCH
10. CVI

Go back to InspireMD (NSPR) Reports Q4 Loss of $0.31

InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

March 28, 2016 8:27 AM EDT

BOSTON, MA -- (Marketwired) -- 03/28/16 -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced its financial and operating results for the fourth quarter and year ended December 31, 2015.

In 2015, InspireMD advanced its strategic transition into the carotid and neuro interventional markets utilizing its proprietary MicroNet" technology. Key activities include announced:

Consistent, positive clinical results, with therapeutic benefits sustained at 12 months from the CGuard" CARENET trial, as well... More